【摘要】 瑞马唑仑是由制药公司PAION AG开发的一种超短效静脉内应用苯二氮?类(benzodiazepine，BZD)药物。在临床应用中，相比其他麻醉镇静药物，如咪达唑仑、丙泊酚等，瑞马唑仑具有起效快、清除率高、作用时间短、恢复快、血流动力学稳定、呼吸抑制作用小等优点。本文就瑞马唑仑的药理学特征和临床应用研究做一综述，为临床的安全用药提供参考。更多还原

【Abstract】 Remimazolam is a very short-acting intravenous benzodiazepine (BZD) drug developed by the pharmaceutical company PAION AG.In clinical application,compared with other anesthetic and sedative drugs,such as Midazolam and Propofol,Remimazolam has the advantages of rapid onset,high clearance rate,short duration of action,quick recovery,stable hemodynamics and small respiratory inhibitory effect.This article reviews the pharmacological characteristics and clinical application research of Remimazolam,providing a reference for safe clinical medication.更多还原